Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumorSanthosh A. Upadhyaya, Amar Gajjar, Arzu Onar‐Thomas et al.|Neuro-Oncology|2022Cited by 29
Comprehensive analysis of <i>MYB/MYBL1</i>-altered pediatric-type diffuse low-grade gliomaDaniel C. Moreira, Jason Chiang, Ibrahim Qaddoumi et al.|Neuro-Oncology|2024Cited by 24